Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9YC7

Plasmodium falciparum M17 aminopeptidase (PfA-M17) bound to inhibitor 3k (MIPS3415)

This is a non-PDB format compatible entry.
Summary for 9YC7
Entry DOI10.2210/pdb9yc7/pdb
DescriptorM17 leucyl aminopeptidase, ZINC ION, CARBONATE ION, ... (10 entities in total)
Functional Keywordsm17 aminopeptidase, aminopeptidase inhibitor, p. falciparum, malaria, hydrolase
Biological sourcePlasmodium falciparum (malaria parasite P. falciparum)
Total number of polymer chains12
Total formula weight715647.89
Authors
Mansouri, M.,McGowan, S.,Webb, C.T. (deposition date: 2025-09-18, release date: 2026-01-28, Last modification date: 2026-02-04)
Primary citationMansouri, M.,De Paoli, A.,Giannangelo, C.,Chowdury, M.,Ngo, A.,Shackleford, D.M.,Webb, C.T.,Lowes, K.N.,Creek, D.J.,Charman, S.A.,Koning-Ward, T.F.,McGowan, S.,Scammells, P.J.
Novel Scaffold Unlocks Potent Cross-Peptidase and Cross-Species Inhibitors as Promising Antimalarial Agents.
J.Med.Chem., 69:1358-1386, 2026
Cited by
PubMed Abstract: Malaria remains a global health burden and the emergence of parasite-resistance to frontline drugs highlights an urgent need for new therapeutics with novel mechanisms of action. Inhibiting aminopeptidases, in particular the M1 and M17 aminopeptidases (A-M1 and A-M17 respectively) has been shown to cause parasite death. In this study, both ligand-based and structure-based design strategies were utilized to identify novel scaffolds that act as dual inhibitors of these enzymes. Structural studies supported the improved activity showing strong hydrophobic and additional hydrogen interactions between the new cores and the S1 pocket of the enzymes. These inhibitors were highly effective against and , showing cross-peptidase and cross-species activity while also retaining activity against multidrug resistant strains. Progression to efficacy studies showed reduction in parasitaemia in mice infected with demonstrating encouraging prospects to develop suitable drug-like candidates for the treatment of malaria.
PubMed: 41525497
DOI: 10.1021/acs.jmedchem.5c02743
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.37 Å)
Structure validation

250359

PDB entries from 2026-03-11

PDB statisticsPDBj update infoContact PDBjnumon